Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227 Hold
2
﹤0.01% 937
2026
Q1
$188 Hold
2
﹤0.01% 922
2025
Q4
$198 Buy
+2
New +$194 ﹤0.01% 930
2025
Q1
Sell
-28
Closed -$1.93K 735
2024
Q4
$1.93K Sell
28
-617
-96% -$44K ﹤0.01% 615
2024
Q3
$36.7K Buy
645
+617
+2,204% +$39.3K 0.01% 296
2024
Q2
$1.7K Sell
28
-617
-96% -$34.9K ﹤0.01% 528
2024
Q1
$36.7K Buy
+645
New +$38.7K 0.01% 321

Other funds holding INCY

Nemes Rush Group's INCY Position: Q2 2026 in Review

Nemes Rush Group held its Incyte (INCY) position steady in Q2 2026 at 2 shares worth $227. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Nemes Rush Group first reported a position in INCY in Q1 2024 and has held it in 7 quarters since. The position peaked at $36.7K in Q3 2024. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Nemes Rush Group held 2 shares of Incyte worth $227 as of Q2 2026.
  • Nemes Rush Group left its Incyte share count unchanged in Q2 2026.
  • Incyte made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #937 holding.
  • Nemes Rush Group first reported a position in Incyte in Q1 2024 and has held it in 7 quarters since.
  • Nemes Rush Group's Incyte position peaked at $36.7K in Q3 2024.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.